Changing disease patterns in focal brain lesion-causing disorders in AIDS

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 4, 1998, Pages 365-371

  Ammassari, Adriana ^a   Scoppettuolo, Giancarlo ^a   Murri, Rita ^a   Pezzotti, Patrizio ^b   Cingolani, Antonella ^a   Del Borgo, Cosmo ^a   De Luca, Andrea ^a   Antinori, Andrea ^a   Ortona, Luigi ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Acquired immunodeficiency syndrome; Anti Toxoplasma prophylaxis; Focal brain lesions; HIV infection; Primary central nervous system lymphoma; Time trends; Toxoplasmic encephalitis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN LYMPHOMA; CANCER RISK; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TOXOPLASMOSIS; VIRUS ENCEPHALITIS;

CYTOMEGALOVIRUS; HERPES; HUMAN IMMUNODEFICIENCY VIRUS; ILEX COOKII; SIMPLEXVIRUS; TOXOPLASMA; TRIXIS;

EID: 0032146769     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199808010-00008     Document Type: Article

References (43)

1. Luft BJ, Hafner R, Korzun AH, et al. TE in patients with acquired immune deficiency syndrome. N Engl J Med 1993;14:403-18.
2. Conn JA, McMeeking A, Cohen W, Jacobs J, Holzman RS. Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome. Am J Med 1989; 89:521-7.
3. Cimino C, Lipton RB, Williams A, Feraru E, Harris C, Hirschfeld A. The evaluation of patients with human immunodeficiency virus-related disorders and brain mass lesions. Arch Intern Med 1991; 151:1381-4.
4. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
5. Baumgartner JE, Rachlin JR, Beckstead JH, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73:206-11.
6. Levy R, Russell E, Yungbluth M, Hidvegi DF, Brody BA, Dal Canto M. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery 1992;30:186-90.
7. Chappell T, Guthrie B, Orenstein J. The role of stereotactic biopsy in the management of HIV-related focal brain lesions. Neurosurgery 1992;30:825-9.
8. Iacoangeli M, Roselli R, Antinori A, et al. Experience with brain biopsy in acquired immune deficiency syndrome related focal brain lesions of the central nervous system. Br J Surg 1994;81: 1508-11.
9. Antinori A, Ammassari A, De Luca, et al. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiological characteristics combined with polymerase chain reaction assay in cerebrospinal fluid. Neurology 1997;48:687-94.
10. Mathews C, Barba D, Fullerton SC. Early biopsy versus empiric treatment with delayed biopsy of non-reponders in suspected HIV-associated cerebral toxoplasmosis: a decision analysis. AIDS 1995; 9:1243-50.
11. Girard PM, Landman R, Gaudebout C, et al. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993;328:1514-20.
12. Oksenhendler E, Charreau I, Tournerie C, Azihary M, Carbon C, Aboulker JP. Toxoplasma gondii infection in advanced HIV infection. AIDS 1994;8:483-7.
13. Bacellar H, Munoz A, Miller EN, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1995. Neurology 1994;44:1892-1900.
14. Antinori A, Murri R, Ammassari A, et al. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. AIDS 1995;9:1343-50.
15. Ammassari A, Murri R, Cingolani A, De Luca A, Antinori A. AIDS-associated cerebral toxoplasmosis: an update on diagnosis and treatment. Curr Top Microbiol Immunol 1996;219:201-14.
16. Jones J, Hanson D, Chu S, et al. and the Adult/Adolescent Spectrum of Disease Group. Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. AIDS 1996;10:1393-9.
17. Goplen A, Dunlop O, Liestol K, Lingjarde O, Brunn J, Mahlen J. The impact of primary central nervous system lymphoma in AIDS patients: a population-based autopsy study from Oslo. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:351-4.
18. De Luca A, Cingolani A, Linzalone A, et al. Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leucoencephalopathy. J Clin Microbiol 1996;34:1343-6.
19. Cinque P, Scarpellini P, Vago L, Linde A, Lazzarin A. Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction. AIDS 1997;11:1-17.
20. Sackett DL, Haynes RB, Gyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown, 1985.
21. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989.
22. Opravil M, Heald A, Lazzarin A, et al. Dapsone-pyrimethamine versus aerosolized pentamidine for combined prophylaxis of PCP anf toxoplasmic encephalitis. Clin Infect Dis 1995;20:531-41.
23. Van Delden C, Gabriel V, Sudre P, Flepp M, von Overbeck J, Hirschel B and the Swiss HIV Cohort Study. Reasons for failure of prevention of Toxoplasma encephalitis. AIDS 1992;10:509-13.
24. Raffi F, Aboulker J-P, Michelet C, et al. A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. AIDS 1997;11:177-84.
25. Eby NL, Grufferman S, Flannelly C, Schold SC, Vogel FS, Bureger P. Increasing incidence of primary brain lymphoma in the US. Cancer 1988;62:2461-5.
26. Cote TR, Manns A, Hardy CR, Yellin FJ, and the AIDS/Cancer Study Group. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. J Natl Cancer Inst 1996;88:675-9.
27. Camilleri-Broet S, Davi F, Feuillard J, et al. High expression of latent membrane protein 1 of Epstein-Barr virus and BCL-2 oncoprotein in acquired immunodeficiency syndrome-related primary brain lymphomas. Blood 1995;86:432-5.
28. Gaidano G, Capello D, Pastore C, et al. Analysis of human herpesvirus type 8 in AIDS-related and AIDS-unrelated primary central nervous system lymphoma. J Infect Dis 1997;175:1193-7.
29. Haverkos H, for the TE Study Group. Assessment of therapy for Toxoplasma encephalitis. Am J Med 1987;82:907-14.
30. Hammer S, Squires K, Hughes M, et al. for the AIDS Clinical Trials Group 320 Team. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.
31. Connors M, Kovacs J, Krevat S, et al. HIV infection induces changes in CD4- T-cell phenotype and depletions within the CD4-T-cell repertoire that are not immediately restored by antiretroviral or immune-based therapies. Nature Med 1997;3:533-40.
32. Autran B, Carcelain G, Li S, et al. Positive effects of combined antiretroviral therapy on CD4- T-cell homeostasis and function in advanced HIV disease. Science 1997;277:112-6.
33. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-5.
34. Kersten MJ, Klein M, Holwerda A, Miedema F, van Oers M. Epstein-Barr virus-specific cytotoxic T cell responses in HIV-1 infection. J Clin Invest 1997;99:1525-33.
35. Cinque P, Brytting M, Vago L, et al. Evaluation of cerebrospinal fluid EBV-DNA from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993;342:398-401.
36. De Luca A, Antinori A, Cingolani A, et al. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma. Br J Haematol 1995;90:844-9.
37. Cingolani A, De Luca A, Larocca LM, et al. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst 1998;90:364-9.
38. O Malley JP, Ziessman HA, Kumar PN, Harkness BA, Tall JG, Pierce PF. Diagnosis of intracranial lymphoma in patients with AIDS: value of 201 TE single-photon emission computed tomography. AJR Am J Roentgenol 1994;163:417-21.
39. Ruiz A, Ganz W, Donovan Post J, et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from Toxoplasma encephalitis in AIDS patients. AJNR Am J Neuroradiol 1994;15: 1885-94.
40. Levine A, Sullivan-Halley J, Pike M, et al. Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival. Cancer 1991;68:2466-72.
41. Antinori A, Ammassari A, Murri R, et. al. Primary central nervous system lymphoma and brain biopsy in AIDS. Lancet 1993;341: 1411-12.
42. Forsyth P, Yahalom J, DeAngelis L. Combined-modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 1994;44:1473-9.
43. Chamberlain M. Long survival in patients with acquired immune deficiency syndrome-related primary central nervous system lymphoma. Cancer 1994;73:1728-30.